Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Australian Family Physician
|
June 3, 2000
The new antipsychotics. How much better are they?
N Keks, P Mazumdar, K Steele
Australian Family Physician
|
April 1, 2000
New developments in schizophrenia
N Keks, P Mazumdar, R Shields
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1997
Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia
B Dean, K Opeskin, G Pavey, et al.
Biological Psychiatry
|
June 15, 1992
Psychotic symptoms resulting from intraventricular infusion of dopamine in Parkinson's disease
J Kulkarni, M Horne, E Butler, et al.
Neurochemistry International
|
April 23, 1999
No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia
B Dean, E Tomaskovic-Crook, K Opeskin, et al.
Biological Psychiatry
|
November 5, 1997
The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia
P L Marzella, C Hill, N Keks, et al.
Journal of Affective Disorders
|
October 2, 2001
A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder
B Dean, G Pavey, M McLeod, et al.
Schizophrenia Research
|
November 15, 1996
Neither protein kinase C nor adenylate cyclase are altered in the striatum from subjects with schizophrenia
K Opeskin, B Dean, G Pavey, et al.
Schizophrenia Research
|
August 9, 2005
Competence to give informed consent in acute psychosis is associated with symptoms rather than diagnosis
V Howe, K Foister, K Jenkins, et al.
Schizophrenia Research
|
July 5, 1996
A clinical trial of the effects of estrogen in acutely psychotic women
J Kulkarni, A de Castella, D Smith, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Australian Family Physician
|
June 3, 2000
The new antipsychotics. How much better are they?
N Keks, P Mazumdar, K Steele
Australian Family Physician
|
April 1, 2000
New developments in schizophrenia
N Keks, P Mazumdar, R Shields
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 1, 1997
Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia
B Dean, K Opeskin, G Pavey, et al.
Biological Psychiatry
|
June 15, 1992
Psychotic symptoms resulting from intraventricular infusion of dopamine in Parkinson's disease
J Kulkarni, M Horne, E Butler, et al.
Neurochemistry International
|
April 23, 1999
No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia
B Dean, E Tomaskovic-Crook, K Opeskin, et al.
Biological Psychiatry
|
November 5, 1997
The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia
P L Marzella, C Hill, N Keks, et al.
Journal of Affective Disorders
|
October 2, 2001
A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder
B Dean, G Pavey, M McLeod, et al.
Schizophrenia Research
|
November 15, 1996
Neither protein kinase C nor adenylate cyclase are altered in the striatum from subjects with schizophrenia
K Opeskin, B Dean, G Pavey, et al.
Schizophrenia Research
|
August 9, 2005
Competence to give informed consent in acute psychosis is associated with symptoms rather than diagnosis
V Howe, K Foister, K Jenkins, et al.
Schizophrenia Research
|
July 5, 1996
A clinical trial of the effects of estrogen in acutely psychotic women
J Kulkarni, A de Castella, D Smith, et al.
Page
of 2